Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I put our 2011 portfolio into the ibox.
Man, I wish I knew how to make it smaller. We're off to the races in 2012, too.
Anybody look at long-term chart of PPHM lately?...absolutely.sickening!
Lower highs and lower lows for a good 10-11 years.
P-P-H-M sing dis song, DOO-DAH, DOO-DAH....
Thanks Ken. I've been watching the tape on it, and can't see any selling. There were 2 million shares short Jan 31, about 25% of the float. That combined with insider buying and morphing from operating loss to profitable should keep the rocket fueled for some time to come. Have a good weekend
PPHM just had a long term head fake.
I am not thinking it shall go up any time soon.
LTS has a negative powerstream in the weekly
I am not convinced it is ready to go yet. The base is formed to launch with if it is ready, though.
You mean it still hasn't come out?
That's been a long time. I am still waiting for the dividends to be paid to us for the EMXC/MPIX deal.
Manti
This is a great pick by you. I just checked the weekly format for longer term trends and it is set to run for a long time. You'll have days where you'll lose but the trend will still be with you. Good going.
HRID INKS DEAL WITH WALL MART. Hammer
$HRID .08 AH news HRID's Azul Instant(TM) Approved for Sale in Walgreens
FORT LAUDERDALE, Fla., Feb. 21, 2012 /PRNewswire via COMTEX/ -- Nouveau Life Pharmaceuticals (soon to be changed from Hybrid Fuels, Inc.), (Pink Sheets: HRID) announced today that the CEO met with Walgreens representatives and received approval to sell Azul Instant(TM) beginning in the Florida market.
"We are excited by Walgreen's decision and are confident in our ability to deliver to one of the nation's largest drug store chains. After we launch in the Florida catalog with Walgreens, we will aggressively penetrate the East Coast, followed by the West Coast and then Midwest. In addition to Walgreens, we are also targeting CVS and GNC," stated Ramiro Cadena, CEO of Nouveau Life Pharmaceuticals.
The Company recently announced the introduction of Azul Instant(TM), an all-natural supplement for ED that provides the millions of men suffering from the condition with a safe alternative to prescription drugs. Developed by a team of experts, the Company's goal is to create the healthiest and most effective all-natural male enhancer ever formulated. Unlike pharmaceutical drugs such as Cialis, Viagra and Levitra, Azul Instant(TM), carries no dangerous side effects.
About Azul Instant(TM)
Azul Instant(TM) was developed by the scientific research and development team of Nouveau Life Pharmaceuticals. The Company developed the formula to provide a safe and natural alternative for erectile dysfunction. Patients will now receive the NATURAL benefits of Azul Instant(TM) without experiencing the side effects associated with prescription medications. While there are other natural alternative supplements on the market today, Azul Instant(TM) is the only male enhancement product that works within 5 minutes. Azul Instant(TM) lasts for up to 48 hours and has proven to help enhance sexual stamina, endurance, strength and energy with no side effects.
Azul Instant(TM) is marketed under Nouveau Life Pharmaceuticals, Inc. For more information, go to www.azulnow.com.
About Hybrid Fuels, Inc.
The company was incorporated in the state of Nevada in 1998 as Polo Equities. It has primarily been a development stage company with management focused on developing innovative business opportunities and further advancing technologies.
Did you see the new option awards for PPHM?
Steven W. King Chief Executive Officer 350,000
Paul J. Lytle Chief Financial Officer 140,000
Joseph S. Shan V.P., Clinical & Regulatory Affairs 140,000
Shelley P.M. Fussey V.P., Intellectual Property 58,000
Jeffrey L. Masten V.P., Quality 58,000
Those boys worked hard to keep the pps under a buck for these awards.
Single-Atom Transistor Is End of Moore's Law; May Be Beginning of Quantum Computing
http://www.sciencedaily.com/releases/2012/02/120219191244.htm
ScienceDaily (Feb. 19, 2012) The smallest transistor ever built in fact, the smallest transistor that can be built has been created using a single phosphorus atom by an international team of researchers at the University of New South Wales, Purdue University and the University of Melbourne.
The single-atom device was described Sunday (Feb. 19) in a paper in the journal Nature Nanotechnology.
Michelle Simmons, group leader and director of the ARC Centre for Quantum Computation and Communication at the University of New South Wales, says the development is less about improving current technology than building future tech.
"This is a beautiful demonstration of controlling matter at the atomic scale to make a real device," Simmons says. "Fifty years ago when the first transistor was developed, no one could have predicted the role that computers would play in our society today. As we transition to atomic-scale devices, we are now entering a new paradigm where quantum mechanics promises a similar technological disruption. It is the promise of this future technology that makes this present development so exciting."
The same research team announced in January that it had developed a wire of phosphorus and silicon just one atom tall and four atoms wide that behaved like copper wire.
Simulations of the atomic transistor to model its behavior were conducted at Purdue using nanoHUB technology, an online community resource site for researchers in computational nanotechnology.
Gerhard Klimeck, who directed the Purdue group that ran the simulations, says this is an important development because it shows how small electronic components can be engineered.
"To me, this is the physical limit of Moore's Law," Klimeck says. "We can't make it smaller than this."
Although definitions can vary, simply stated Moore's Law holds that the number of transistors that can be placed on a processor will double approximately every 18 months. The latest Intel chip, the "Sandy Bridge," uses a manufacturing process to place 2.3 billion transistors 32 nanometers apart. A single phosphorus atom, by comparison, is just 0.1 nanometers across, which would significantly reduce the size of processors made using this technique, although it may be many years before single-atom processors actually are manufactured.
The single-atom transistor does have one serious limitation: It must be kept very cold, at least as cold as liquid nitrogen, or minus 391 degrees Fahrenheit (minus 196 Celsius).
"The atom sits in a well or channel, and for it to operate as a transistor the electrons must stay in that channel," Klimeck says. "At higher temperatures, the electrons move more and go outside of the channel. For this atom to act like a metal you have to contain the electrons to the channel.
"If someone develops a technique to contain the electrons, this technique could be used to build a computer that would work at room temperature. But this is a fundamental question for this technology."
Although single atoms serving as transistors have been observed before, this is the first time a single-atom transistor has been controllably engineered with atomic precision. The structure even has markers that allow researchers to attach contacts and apply a voltage, says Martin Fuechsle, a researcher at the University of New South Wales and lead author on the journal paper.
"The thing that is unique about what we have done is that we have, with atomic precision, positioned this individual atom within our device," Fuechsle says.
Simmons says this control is the key step in making a single-atom device. "By achieving the placement of a single atom, we have, at the same time, developed a technique that will allow us to be able to place several of these single-atom devices towards the goal of a developing a scalable system."
The single-atom transistor could lead the way to building a quantum computer that works by controlling the electrons and thereby the quantum information, or qubits. Some scientists, however, have doubts that such a device can ever be built.
"Whilst this result is a major milestone in scalable silicon quantum computing, it does not answer the question of whether quantum computing is possible or not," Simmons says. "The answer to this lies in whether quantum coherence can be controlled over large numbers of qubits. The technique we have developed is potentially scalable, using the same materials as the silicon industry, but more time is needed to realize this goal."
Klimeck says despite the hurdles, the single-atom transistor is an important development.
"This opens eyes because it is a device that behaves like metal in silicon. This will lead to many more discoveries."
The research project spanned the globe and was the result of many years of effort.
"When I established this program 10 years ago, many people thought it was impossible with too many technical hurdles. However, on reading into the literature I could not see any practical reason why it would not be possible," Simmons says. "Brute determination and systemic studies were necessary -- as well as having many outstanding students and postdoctoral researchers who have worked on the project."
Klimeck notes that modern collaboration and community-building tools such as nanoHUB played an important role.
"This was a trans-Pacific collaboration that came about through the community created in nanoHUB. Now Purdue graduate students spend time studying at the University of New South Wales, and their students travel to Purdue to learn more about nanotechnology. It has been a rewarding collaboration, both for the scientific discoveries and for the personal relationships that were formed."
Is the Duke Report out? LOL.
Daily charts are suggesting that Tuesday PPHM may go up.
I see the d+ rising and the aroon up at count one. Let's see if a few days growth can help you.
Institutions--Net decrease of 2 million shares of PPHM,doo-dah
DOO-DAH institutional holdings
Reading that article about hep C just makes me shake my head at the way this country handles pharma: one huge monopoly set up to take money from the people.
As some here know, I've invested in MZEI. While doing my dd, I was conversing with the ceo and he mentioned that years ago their focus was on using ozone to sterilize blood, rather than facilities as is the current focus. He told me that they had gone so far as to do clincal trials in a third world country on 40 individuals with hep C and they completely cured 36 of them. The 4 that weren't cured had already had a previous treatment by drugs that had damaged their immune systems. Too bad the fda is set up to protect the pharma monopoly rather than the people...
SCON DD summary - Placement done, milestones to come.
With recent placement at 1.05 for 4 million they are about ready to start installing their new state of art production facililty
- New low cost technology for Superconducting Wire
- Product samples meeting industry criteria and validated !
- Took possesion of new 90.000 acre state of art facility in January 2012
"The company will set up in a 94,000-square-foot Class A semiconductor manufacturing facility previously occupied by Applied Materials Inc"
Here an overview of their plans.
Note the wire cost with is lot less than some of their competitors allready in the market such as AMSC
Wire cost projections
Full update in pdf here: http://www.suptech.com/pdf_presentations/2012invpresentation.pdf
Production partner likely there due to supply restraints in the sector.
Recent and more outlook there than there was before, worth the read:
http://www.statesman.com/business/technology/vacant-clean-rooms-find-new-life-in-superconducting-2039934.html
A) Superconductor Technologies Inc. Takes Possession of Advanced Manufacturing Center of Excellence in Austin, TX
http://finance.yahoo.com/news/Superconductor-Technologies-pz-3998953240.html?x=0
B) Superconductor Technologies Inc. Completes Testing of Conductus(R) 2G HTS Wire with General Cable Superconductor Ltd. for HTS Roebel Cable Applications
Successfully meeting critical current and power handling objectives
http://finance.yahoo.com/news/Superconductor-Technologies-pz-2107429496.html?x=0
C)Superconductor Technologies Inc. Commits Supply of Conductus(R) 2G HTS Wire to Leading Provider of High Power Transmission Cables Demonstration project scheduled to be completed by end of 2012
http://finance.yahoo.com/news/Superconductor-Technologies-pz-1237715445.html?x=0
Gilead Suffers First Hep C Drug Setback
By Adam Feuerstein
http://www.thestreet.com/_yahoo/story/11423015/1/gilead-suffers-first-hep-c-drug-setback.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
FOSTER CITY, Calif. (TheStreet) Gilead Sciences(GILD) just had its first stumble in the race to develop an all-oral therapy for hepatitis C.
A two-drug regimen of Gilead's experimental GS-7977 plus ribavirin failed to suppress the hepatitis C virus in a group of difficult-to-treat patients who had also failed prior therapy, Gilead announced Friday.
Gilead's GS-7977 streak as the ultimate, flawless hepatitis C drug has now ended. Friday's negative results are a setback and not a fatal blow to the drug's future. However, Gilead spent $11 billion to gain control of GS-7977 through the acquisition of Pharmasset so any failure, no matter how small, is sure to be magnified in the eyes of investors.
Gilead shares plunged 19% to $44.50 in Friday pre-market trading.
In this study, ten hepatitis C genotype 1 patients with a prior "null" response to interferon and ribavirin were treated with a combination of GS-7977 plus ribavirin for 12 weeks. Within four weeks of completing treatment, six of eight patients relapsed, meaning the hepatitis C virus, which had been suppressed, came roaring back. Two patients have not relapsed, however they have only reached the two week post-treatment time point, Gilead said.
Null responders are among the most difficult to treat hepatitis C patients because prior therapy has not worked for them.
"These data answer an important question about the use of GS-7977 and ribavirin for the treatment of genotype 1 null responder patients, suggesting that additional direct acting antivirals may be necessary to effectively treat this patient population," said Norbert Bischofberger, Gilead's research chief, in a statement.
Further data on GS-7977 is coming soon, including important results from a study testing the drug in combination with ribavirin in genoptype 1 patients who have not been previously treated.
A chink in the previous untarnished armor of GS-7977 may mean a boost for other companies developing new oral hepatitis C drugs, including Vertex Pharmaceuticals(VRTX_), Bristol-Myers Squibb(BMY_) and Idenix Pharmaceuticals(IDIX) .. Written by Adam Feuerstein in Boston.
Might have to wait on their Duke Report....
Looks like any corrections will be sideways. No sellers yet.
Hi Gwen, and I remember when I purchased shares in. "fruit" company called Apple Computer .. And they were about to go under when MSFT stepped in and Bill loaned Steve and Apple $100 millin for equity stake ..to this day, I still have faith in Drs Thorpe and crew, the SRB, and Bavi AC ... Any Bavi action on AV would be a bonus as always, and Cotara is a wildcard, getting closer to "playable" .. The BOD is as horrific as the SRB is awesone imho ... The clock keeps ticking and as time is the world's true currency, we have been biding our time, some suffering more than others obviously, but one morning you just may wake up with news that sends this PARABOLIC, or news that creates a precipitous descent ... Time, faith, due diligence, hope and science may a strange cocktail of bedfellows, but such is life @ PPHM ... If, Carroling Johnson would step down, and Roche/DNA man takes the helm, you get a $3-4 stock on current trial results alone on the promise ... The anchor and albatross has been the BOD & their blatant lack of street credibility as well as the ignorant PIPE decisions which have bleed the shareholders into almost oblivion .. And yet I purchase more? Yup, hope sorings eternal, and maybe the mega grand slam I hit on PTSC from 1 penny to dollars an be replicted despite the same cast of dubious characters ... Peace and blessings as always .. Mark
Good for you Mark. I hope your instincts prove correct. At this point I wouldn't buy another share until we get some significant proof.
Btw, I bought a nice chunk of "the junk" as lemmy calls it today @ .912, when I had a .92 limit order in @ Fidelity .. They "executed" the trade below the limit which restores hope in mankind a lil bit, and reduced the fee to $7.95 for all the fragmented transactions they combined .. So more zippity doo dah in da stable ... Mark
P-P-H-M sing dis song, DOO-DAH, DOO-DAH....
Quite possible. There was news today, so it may have gotten ahead of itself when they started buying Friday in anticipation and then continued today. If it does pull back, it should be on light volume.
That is nice Manti
I am sensing a sort of pull back tomorrow. The d+ looks stretched a bit and usually means some draw back the following day. Let's watch it tomorrow.
INDEED, BUT IN THE END, SHE HELPED HERSELF.
We're going to miss her.
yes, he probably is. she made the wrong choices and this is how it ends.
HOW TRUE ..
BUT HE'S STILL A P.O.S......TOTAL GARBAGE
people make their own choices. nothing more to say.
SHE WAS HELPED ALONG
BY BOBBY BROWN AFTER SHE MARRIED HIM ........HE'S A P.O.S.....
NO SURPRISE THE WAY SHE WAS GOING.
A BEAUTIFUL WOMAN AND GREAT TALENT ... WHAT A WASTE. AND SADLY, SHE DID IT ALL TO HERSELF.
Whitney Houston, Iconic Pop Star, Dies at 48
You were right about the under 1 buck.
I thought they did gator.
I thought it was yesterday but chartinator says sometime in May....he also mentioned that many funds already have shares of Facebook in their portfolios. Companies like GSVC is supposed to have many shares and will move very well because of it later. Just a thought.
HANG IN THERE GUYS.....
SHOULD BE ABLE TO GET SOME MORE UNDER A BUCK SOON .A LEOPARD NEVER CHANGES IT'S SPOTS ......
Maybe if they'd stop the printing presses they could get some traction.
Gee, what an observation about PPHM. You mean like in December 2011, and in August 2011, and again in August 2011, and the time before that and the time before that and the time before that? Every time is always "the time" it will move. It's moves all right. Lower highs and lower lows for a good decade.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |